Well, we just passed the midway mark for August 2022 and it looks like a potentially good month for ANDA approval actions. Thus far (at least posted through August 16th), the OGD has issued thirty full-approval actions and eleven tentative-approval actions, well on its way to a high-70s or low-to-mid-80s number of approval actions.
We will update you around the end of the first week in September to see how the unofficial totals look for August. Until then, you can track the OGD’s approval actions on the FDA’s “All Approvals” list here.
